| Crest Urgent Care | |
|
100 Smithfield Ave Pawtucket RI 02860-3497 | |
| (401) 725-8600 | |
| (140) 172-5806 |
| Full Name | Crest Urgent Care |
|---|---|
| Speciality | Clinic/center - Primary Care |
| Location | 100 Smithfield Ave, Pawtucket, Rhode Island |
| Authorized Official Name and Position | James O'hair (DIRECTOR) |
| Authorized Official Contact | 4017258600 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Crest Urgent Care 100 Smithfield Ave Pawtucket RI 02860-3497 Ph: (401) 725-8600 | Crest Urgent Care 100 Smithfield Ave Pawtucket RI 02860-3497 Ph: (401) 725-8600 |
| NPI Number | 1073813713 |
|---|---|
| Provider Enumeration Date | 10/28/2010 |
| Last Update Date | 10/28/2010 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073813713 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | PA00565 (Rhode Island) | Primary |
News Archive
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced data from a Phase 1 clinical trial evaluating oral ridaforolimus, its investigational mTOR inhibitor, in combination with bevacizumab (Avastin®) in heavily pretreated patients with refractory metastatic solid tumors. The data were presented at the Joint Multidisciplinary Congress of the 15th annual European Cancer Organization (ECCO) and the 34th annual European Society of Medical Oncology (ESMO) taking place in Berlin, Germany.
Illicit drug users are at increased risk of being exposed to microbial pathogens and are more susceptible to serious infections say physicians writing in the Journal of Medical Microbiology.
Australia's adult stem cell company, Mesoblast Limited has announced that the United States Food and Drug Administration (US FDA) has cleared the Investigational New Drug Submission (IND) of its US-based sister company, Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf', adult stem cells for patients with heart attacks.
Combining erlotinib with bevacizumab could prolong progression-free survival in patients being treated for epidermal growth factor receptor-mutated non-small-cell lung cancer, phase II trial results suggest.
› Verified 7 days ago
Heritage Medical Associates Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 131 Beechwood Ave, Pawtucket, RI 02860 Phone: 401-475-1999 Fax: 401-475-6932 | |
Armistice Primary Care, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 209 Armistice Blvd, Pawtucket, RI 02860 Phone: 401-725-4100 Fax: 401-728-5010 | |
Primary Care Medical Associates, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 109 Beechwood Ave, Pawtucket, RI 02860 Phone: 401-729-6151 | |
American Current Care P.a., Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 203 Concord Street, Suite 301, Pawtucket, RI 02860 Phone: 401-722-8880 Fax: 401-723-9320 | |
Quick Clever Care Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 333 School St Ste 305, Pawtucket, RI 02860 Phone: 617-680-4202 | |
Hillside Family And Community Medicine, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 727 East Ave, Pawtucket, RI 02860 Phone: 401-725-6160 Fax: 401-722-5430 |